Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication November 12, 2018
- Accepted for publication March 26, 2019
- Published online November 1, 2019.
Article Versions
- previous version (March 29, 2019 - 13:40).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Hossein Jadvar1,
- Erik M. Velez1,
- Bhushan Desai1,
- Lingyun Ji2,
- Patrick M. Colletti1 and
- David I. Quinn3
- 1Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California
- 2Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California; and
- 3Division of Cancer Medicine, Department of Medicine, Kenneth J. Norris, Jr., Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California
- For correspondence or reprints contact: Hossein Jadvar, Department of Radiology, University of Southern California, 2250 Alcazar St., CSC 102, Los Angeles, CA 90033. E-mail: jadvar{at}med.usc.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
- Cut Point Identification of Continuous Biomarkers: A Challenge That Goes Beyond Statistical Aspects
- Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
- A Prospective Trial of 68Ga-PSMA and 18F-FDG PET/CT in Nonmetastatic Prostate Cancer Patients with an Early PSA Progression During Castration
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment